IDEAYA Biosciences Inc.

12/10/2024 | Press release | Distributed by Public on 12/10/2024 05:02

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.